John Glenn Sells 2,500 Shares of Iradimed Corporation (NASDAQ:IRMD) Stock

Iradimed Corporation (NASDAQ:IRMD) CFO John Glenn sold 2,500 shares of the firm’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $54.18, for a total transaction of $135,450.00. Following the sale, the chief financial officer now owns 4,383 shares in the company, valued at $237,470.94. The trade was a 36.32 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Iradimed Stock Down 0.2 %

IRMD stock traded down $0.09 during trading on Monday, reaching $53.84. The company’s stock had a trading volume of 29,204 shares, compared to its average volume of 48,532. The company’s fifty day moving average is $51.69 and its 200-day moving average is $47.27. The company has a market capitalization of $682.09 million, a P/E ratio of 36.87 and a beta of 0.79. Iradimed Corporation has a 1 year low of $40.18 and a 1 year high of $57.95.

Iradimed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, November 25th. Investors of record on Friday, November 15th were given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 1.11%. The ex-dividend date of this dividend was Friday, November 15th. Iradimed’s dividend payout ratio is currently 41.10%.

Institutional Trading of Iradimed

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Shaker Investments LLC OH boosted its stake in Iradimed by 1.7% in the 2nd quarter. Shaker Investments LLC OH now owns 20,605 shares of the medical equipment provider’s stock worth $905,000 after purchasing an additional 347 shares during the period. Jacobs Levy Equity Management Inc. lifted its holdings in shares of Iradimed by 1.9% in the third quarter. Jacobs Levy Equity Management Inc. now owns 24,779 shares of the medical equipment provider’s stock worth $1,246,000 after buying an additional 472 shares in the last quarter. ClariVest Asset Management LLC boosted its position in shares of Iradimed by 2.9% during the second quarter. ClariVest Asset Management LLC now owns 17,666 shares of the medical equipment provider’s stock worth $776,000 after acquiring an additional 494 shares during the last quarter. Huntington National Bank grew its stake in Iradimed by 51.3% during the third quarter. Huntington National Bank now owns 1,487 shares of the medical equipment provider’s stock valued at $75,000 after acquiring an additional 504 shares in the last quarter. Finally, Cim LLC grew its stake in Iradimed by 5.9% during the second quarter. Cim LLC now owns 10,089 shares of the medical equipment provider’s stock valued at $464,000 after acquiring an additional 561 shares in the last quarter. Institutional investors own 92.34% of the company’s stock.

Iradimed Company Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.